EASY BIO,Inc. (353810.KQ)

KRW 4570.0

(0.44%)

Long Term Debt Summary of EASY BIO,Inc.

EASY BIO,Inc.'s latest annual long term debt in 2023 was 30 Billion KRW , up 74.49% from previous year.
EASY BIO,Inc.'s latest quarterly long term debt in 2024 Q1 was 77.13 Billion KRW , up 157.13% from previous quarter.
EASY BIO,Inc. reported annual long term debt of 17.19 Billion KRW in 2022, up 251.51% from previous year.
EASY BIO,Inc. reported annual long term debt of 4.89 Billion KRW in 2021, down -70.46% from previous year.
EASY BIO,Inc. reported quarterly long term debt of 146.23 Billion KRW for 2024 Q2, up 89.58% from previous quarter.
EASY BIO,Inc. reported quarterly long term debt of 17.19 Billion KRW for 2023 Q2, down -0.29% from previous quarter.

Annual Long Term Debt Chart of EASY BIO,Inc. (2023 - 2020)

Historical Annual Long Term Debt of EASY BIO,Inc. (2023 - 2020)

Year	Long Term Debt	Long Term Debt Growth
2023	30 Billion KRW	74.49%
2022	17.19 Billion KRW	251.51%
2021	4.89 Billion KRW	-70.46%
2020	16.55 Billion KRW	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	77.13 Billion KRW	157.13%
2024 Q2	146.23 Billion KRW	89.58%
2023 Q2	17.19 Billion KRW	-0.29%
2023 FY	30 Billion KRW	74.49%
2023 Q4	30 Billion KRW	74.83%
2023 Q3	17.15 Billion KRW	-0.18%
2023 Q1	17.24 Billion KRW	0.28%
2022 Q1	4.74 Billion KRW	-2.98%
2022 FY	17.19 Billion KRW	251.51%
2022 Q4	17.19 Billion KRW	-13.09%
2022 Q3	19.78 Billion KRW	321.45%
2022 Q2	4.69 Billion KRW	-1.09%
2021 Q4	4.89 Billion KRW	-67.77%
2021 Q3	15.17 Billion KRW	-8.13%
2021 Q2	16.52 Billion KRW	-0.1%
2021 FY	4.89 Billion KRW	-70.46%
2021 Q1	16.53 Billion KRW	-0.13%
2020 Q3	2.86 Billion KRW	90.64%
2020 Q4	16.55 Billion KRW	478.67%
2020 Q2	1.5 Billion KRW	0.0%
2020 FY	16.55 Billion KRW	0.0%

Peer Long Term Debt Comparison of EASY BIO,Inc.

Name	Long Term Debt	Long Term Debt Difference
HLB Co., Ltd.	17.93 Billion KRW	-67.287%
iNtRON Biotechnology, Inc.	258.29 Million KRW	-11514.633%
BINEX Co., Ltd.	5.57 Billion KRW	-437.793%
Bioneer Corporation	12.5 Billion KRW	-140.0%
Anterogen.Co.,Ltd.	- KRW	-Infinity%
MEDIPOST Co., Ltd.	6.99 Billion KRW	-328.883%
CrystalGenomics, Inc.	29.88 Billion USD	-0.37%
Helixmith Co., Ltd	151.68 Million KRW	-19678.481%
Chabiotech Co.,Ltd.	95.06 Billion KRW	68.444%
Medy-Tox Inc.	1.22 Billion KRW	-2347.298%
Peptron, Inc.	4.5 Billion KRW	-566.667%
Amicogen, Inc.	70.65 Billion KRW	57.54%
Genexine, Inc.	22.68 Billion KRW	-32.267%
HLB Therapeutics Co.,Ltd.	1.84 Billion KRW	-1530.266%
LegoChem Biosciences, Inc.	528.37 Million KRW	-5577.81%
ALTEOGEN Inc.	1.24 Billion KRW	-2301.428%
PharmaResearch Co., Ltd.	970.71 Million KRW	-2990.499%
SillaJen, Inc.	8.13 Billion KRW	-268.738%
JETEMA, Co., Ltd.	60 Billion KRW	50.0%
OliX Pharmaceuticals,Inc	35.36 Billion KRW	15.162%
Genomictree Inc.	97.51 Million KRW	-30664.29%
MedPacto, Inc.	1.68 Billion KRW	-1678.362%
D&D Pharmatech	5.12 Billion KRW	-485.866%
GI Innovation, Inc.	2.9 Billion KRW	-933.055%